Stay updated on NANT NSCLC Vaccine Combo Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the NANT NSCLC Vaccine Combo Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NANT NSCLC Vaccine Combo Immunotherapy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T12:24:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:59:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link instead of its prior content. The site revision label also changes from v3.7.0 to v3.7.1.
    Difference
    0.6%
    Check dated 2026-10-12T14:08:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page no longer displays the 403 Forbidden message or its Home link, but no study record details are visible.
    Difference
    0.5%
    Check dated 2026-10-05T13:44:49.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error page elements (doctype, HTML header with 403 Forbidden title) and the Home navigation link from the page, indicating the error state is no longer displayed in this context.
    Difference
    0.5%
    Check dated 2026-09-28T16:40:20.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, indicating the page is currently inaccessible. The additions include the 403 message and the page chrome (header/footer) with revision metadata (Revision: v3.7.0).
    Difference
    24%
    Check dated 2026-09-21T21:49:26.000Z thumbnail image

Stay in the know with updates to NANT NSCLC Vaccine Combo Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NANT NSCLC Vaccine Combo Immunotherapy Clinical Trial page.